Addgene: pTRIP-SFFV-mtagBFP-2A
Comparison of promoters. (a) Schematic representation of lentivirus... | Download Scientific Diagram
Addgene: pCVL-UCOE-SFFV-TLR-MCV1
Addgene: pHR-SFFV-dCas9-BFP
Addgene: pMuLE ENTR SFFV tdTomato L5-L2
Extensive Methylation of Promoter Sequences Silences Lentiviral Transgene Expression During Stem Cell Differentiation In Vivo: Molecular Therapy
Addgene: pL-CRISPR.SFFV.GFP
A2UCOE gives rise to stable eGFP expression in P19 cells compared to... | Download Scientific Diagram
Addgene: pL-U6-sgRNA-SFFV-Puro-P2A-EGFP
Products
Physiological Promoters Reduce the Genotoxic Risk of Integrating Gene Vectors: Molecular Therapy
Biochemical Correction of X-CGD by a Novel Chimeric Promoter Regulating High Levels of Transgene Expression in Myeloid Cells: Molecular Therapy
Physiological regulation of transgene expression by a lentiviral vector containing the A2UCOE linked to a myeloid promoter | Gene Therapy
Addgene
Addgene: pHR-UCOE-SFFV-dCas9-KRAB(Kox1)-MeCP2-P2A-EGFP
Promoter optimisation of lentiviral vectors for efficient insulin gene expression in canine mesenchymal stromal cells: potential surrogate beta cells - Gautam - 2016 - The Journal of Gene Medicine - Wiley Online Library
Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences | Gene Therapy
▷ Vector Backbone pLenti-U6-sgRNA-SFFV-Cas9-2A-Puro
Addgene: pHR_SFFV
Addgene: pHR-SFFV-GFP1-10
Promoter considerations in the design of lentiviral vectors for use in treating lysosomal storage diseases: Molecular Therapy - Methods & Clinical Development
Lentiviral vector design. All vectors contain GFP as reporter gene... | Download Scientific Diagram
Addgene: pL-SFFV.Reporter.RFP657.PAC
Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases | Scientific Reports
DNA Nicks Promote Efficient and Safe Targeted Gene Correction | PLOS ONE
Addgene: sgRNA.SFFV.tRFP
Plasmid constructs and corresponding SIDD profiles. Column (a) shows... | Download Scientific Diagram
Promoter considerations in the design of lentiviral vectors for use in treating lysosomal storage diseases: Molecular Therapy - Methods & Clinical Development
